
BAY8002
CAS No. 724440-27-1
BAY8002( BAY 8002 | BAY-8002 )
Catalog No. M20102 CAS No. 724440-27-1
BAY-8002 is a potent dual MCT1/2 inhibitor (IC50 values are 3 8 and 12 nM at rat (C6) human (DLD-1) and mouse (4T1) MCT1 respectively).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 68 | In Stock |
![]() ![]() |
10MG | 102 | In Stock |
![]() ![]() |
25MG | 178 | In Stock |
![]() ![]() |
50MG | 320 | In Stock |
![]() ![]() |
100MG | 520 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameBAY8002
-
NoteResearch use only, not for human use.
-
Brief DescriptionBAY-8002 is a potent dual MCT1/2 inhibitor (IC50 values are 3 8 and 12 nM at rat (C6) human (DLD-1) and mouse (4T1) MCT1 respectively).
-
DescriptionBAY-8002 is a potent dual MCT1/2 inhibitor (IC50 values are 3 8 and 12 nM at rat (C6) human (DLD-1) and mouse (4T1) MCT1 respectively).
-
In VitroBAY-8002 is an inhibitor of MCT1, with an IC50 of 85 nM in the MCT1-expressing DLD-1 cells, displays excellent selectivity against MCT4 (IC50 >50 μM in EVSA-T cells).
-
In VivoBAY-8002 (80 and 160 mg/kg, p.o., twice daily, for more than 26 days) significantly inhibits tumor growth in Raji tumor-bearing mice. Animal Model:Female NOD SCID mice bearing Raji cells (7-10 weeks old) Dosage:80 and 160 mg/kg Administration:P.O. twice daily for more than 26 days Result:Inhibited tumor growth with no obvious body weight loss, but showed no effect on tumor regression.
-
SynonymsBAY 8002 | BAY-8002
-
PathwayMembrane Transporter/Ion Channel
-
TargetMonocarboxylate Transporter
-
RecptorMCT1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number724440-27-1
-
Formula Weight415.85
-
Molecular FormulaC20H14ClNO5S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 50 mg/mL (120.24 mM)
-
SMILESOC(=O)c1ccccc1NC(=O)c1cc(ccc1Cl)S(=O)(=O)c1ccccc1
-
Chemical Name2-(2-chloro-5-(phenylsulfonyl)benzamido)benzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Quanz M et al. Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance. Mol Cancer Ther. 2018 Nov;17(11):2285-2296.
molnova catalog



related products
-
AR-C155858
AR-C155858 is an inhibitor of monocarboxylate transporter MCT1 and MCT2 (Kis: 2.3 nM and 10 nM).
-
7-(Diethylamino)coum...
7-(Diethylamino)coumarin-3-carboxylic acid(7ACC) selectively affects a single part of the MCT symporter translocation cycle leading to strict inhibition of lactate influx. This singular activity is associated with antitumor effects less prone to resistance and side effects.
-
Coumarin343
Coumarin343 inhibits monocarboxylic acid transporter protein 4 with IC50 values in the range of 0.01-100 μM.